KGP-25

• Target :

  Sodium Channel|||GABA Receptor

• Related Pathways :

  Membrane transporter/Ion channel|||Neuroscience

• Bioactivity :

  KGP-25 is an inhibitor of the voltage-gated sodium channel 1.8 (Nav1.8), utilized for analgesia by targeting the peripheral nervous system (PNS) . Additionally, it targets the ?-aminobutyric acid subtype A receptor (GABAA) in the central nervous system (CNS) for use as a general anesthetic.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C